Pylarify

piflufolastat F 18

Approval

ApplicationNDA 214793
Approval dateMay 26, 2021
Approval year2021
SponsorProgenics Pharms INC

FDA-approved use

To identify prostate-specific membrane antigen-positive lesions in prostate cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Pylarify: